# Phase II Trial of Allovectin-7® for Head and Neck Cancer

> **NCT00050388** · PHASE3 · COMPLETED · sponsor: **Vical**

## Conditions studied

- Head and Neck Cancer
- Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
- Head and Neck Neoplasms
- Carcinoma of the Head and Neck

## Interventions

- **GENETIC:** Allovectin-7®

## Key facts

- **NCT ID:** NCT00050388
- **Lead sponsor:** Vical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** — (—)
- **Last updated:** 2008-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050388, "Phase II Trial of Allovectin-7® for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00050388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*